Biomerica Receives Notice Of Patent Allowance In China For A Potential Innovative Technology That Includes An Artificial Intelligence Claim For Predicting Foods That Contain Ingredients That Cause Adverse Reactions In Patients
Portfolio Pulse from Happy Mohamed
Biomerica Inc. (NASDAQ:BMRA) has received a Notice of Allowance from the China National Intellectual Property Administration for a patent application covering an AI-based system to predict and prevent adverse food reactions using personal medical data. The patent strengthens the company's intellectual property portfolio in science, diet, and technology.
June 21, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biomerica receives a patent allowance in China for an AI-based system to predict and prevent adverse food reactions, strengthening its intellectual property portfolio.
The patent allowance in China for Biomerica's AI-based system to predict and prevent adverse food reactions using personal medical data strengthens the company's intellectual property portfolio in the area of science, diet, and technology. This development could potentially lead to new products and services, expanding the company's market reach and positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100